INMUNE BIO INC. Excess Stock, Shares Issued
INMUNE BIO INC. (INMB) had Excess Stock, Shares Issued of 74.07 thousand shares as of 2022-12-31, per its 10-K filed 2023-03-02.
Discontinued › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure
us-gaap:ExcessStockSharesIssued · last filed 2023-03-02
- 2022-12-31: Excess Stock, Shares Issued 74.07K shares.
- 2021-06-10: Excess Stock, Shares Issued 192.53K shares.
| Period end | Excess Stock, Shares Issued |
|---|---|
| 2022-12-31 | 74.07K shares 10-K · filed 2023-03-02 |
| 2021-06-10 | 192.53K shares 10-K · filed 2023-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |